PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
The cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2015/374520 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832556451621502976 |
---|---|
author | Juhyun Song So Yeong Cheon Won Taek Lee Kyung Ah Park Jong Eun Lee |
author_facet | Juhyun Song So Yeong Cheon Won Taek Lee Kyung Ah Park Jong Eun Lee |
author_sort | Juhyun Song |
collection | DOAJ |
description | The cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system that are unrelated to its role as a PKA inhibitor. We have investigated the role of H89 in ischemic and reperfusion injury. First, we examined the expression of postsynaptic density protein 95 (PSD95), microtubule-associated protein 2 (MAP2), and synaptophysin in mouse brain after middle cerebral artery occlusion injury. Next, we examined the role of H89 pretreatment on the expression of brain-derived neurotrophic factor (BDNF), PSD95, MAP2, and the apoptosis regulators Bcl2 and cleaved caspase-3 in cultured neuroblastoma cells exposed to hypoxia and reperfusion injury. In addition, we investigated the alteration of AKT activation in H89 pretreated neuroblastoma cells under hypoxia and reperfusion injury. The data suggest that H89 may contribute to brain recovery after ischemic stroke by regulating neuronal death and proteins related to synaptic plasticity. |
format | Article |
id | doaj-art-0e63defa940a428993f82b296ea1a714 |
institution | Kabale University |
issn | 2090-5904 1687-5443 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Neural Plasticity |
spelling | doaj-art-0e63defa940a428993f82b296ea1a7142025-02-03T05:45:17ZengWileyNeural Plasticity2090-59041687-54432015-01-01201510.1155/2015/374520374520PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic InjuryJuhyun Song0So Yeong Cheon1Won Taek Lee2Kyung Ah Park3Jong Eun Lee4Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaThe cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system that are unrelated to its role as a PKA inhibitor. We have investigated the role of H89 in ischemic and reperfusion injury. First, we examined the expression of postsynaptic density protein 95 (PSD95), microtubule-associated protein 2 (MAP2), and synaptophysin in mouse brain after middle cerebral artery occlusion injury. Next, we examined the role of H89 pretreatment on the expression of brain-derived neurotrophic factor (BDNF), PSD95, MAP2, and the apoptosis regulators Bcl2 and cleaved caspase-3 in cultured neuroblastoma cells exposed to hypoxia and reperfusion injury. In addition, we investigated the alteration of AKT activation in H89 pretreated neuroblastoma cells under hypoxia and reperfusion injury. The data suggest that H89 may contribute to brain recovery after ischemic stroke by regulating neuronal death and proteins related to synaptic plasticity.http://dx.doi.org/10.1155/2015/374520 |
spellingShingle | Juhyun Song So Yeong Cheon Won Taek Lee Kyung Ah Park Jong Eun Lee PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury Neural Plasticity |
title | PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury |
title_full | PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury |
title_fullStr | PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury |
title_full_unstemmed | PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury |
title_short | PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury |
title_sort | pka inhibitor h89 n 2 p bromocinnamylamino ethyl 5 isoquinolinesulfonamide attenuates synaptic dysfunction and neuronal cell death following ischemic injury |
url | http://dx.doi.org/10.1155/2015/374520 |
work_keys_str_mv | AT juhyunsong pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury AT soyeongcheon pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury AT wontaeklee pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury AT kyungahpark pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury AT jongeunlee pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury |